Literature DB >> 2566750

Fenoterol and asthma mortality.

N Pearce, J Crane, C Burgess, R Beasley, R Jackson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2566750     DOI: 10.1016/s0140-6736(89)92768-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Pharmacoeconomic consequences of measurement and modification of hospital drug use.

Authors:  L L Ioannides-Demos; G M Eckert; A J McLean
Journal:  Pharmacoeconomics       Date:  1992-07       Impact factor: 4.981

2.  Statistical methods in pharmacoepidemiology. Principles in managing error.

Authors:  S Suissa
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

Review 3.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

Review 4.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

Review 5.  Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery.

Authors:  Anthony Yiu-Ho Woo; Ying Song; Rui-Ping Xiao; Weizhong Zhu
Journal:  Br J Pharmacol       Date:  2014-12-17       Impact factor: 8.739

Review 6.  β₂ AR agonists in treatment of chronic heart failure: long path to translation.

Authors:  Mark I Talan; Ismayil Ahmet; Riu-Ping Xiao; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2010-10-01       Impact factor: 5.000

7.  Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.

Authors:  Ismayil Ahmet; Edward G Lakatta; Mark I Talan
Journal:  Heart Fail Rev       Date:  2005-12       Impact factor: 4.214

8.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

Authors:  N Pearce; J Grainger; M Atkinson; J Crane; C Burgess; C Culling; H Windom; R Beasley
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

9.  Recent trends in the use of inhaled beta 2-adrenergic agonists and inhaled corticosteroids in Saskatchewan.

Authors:  B Habbick; M J Baker; M McNutt; D W Cockcroft
Journal:  CMAJ       Date:  1995-11-15       Impact factor: 8.262

10.  Therapeutic efficacy of a combination of a beta1-adrenoreceptor (AR) blocker and beta2-AR agonist in a rat model of postmyocardial infarction dilated heart failure exceeds that of a beta1-AR blocker plus angiotensin-converting enzyme inhibitor.

Authors:  Ismail Ahmet; Chris Morrell; Edward G Lakatta; Mark I Talan
Journal:  J Pharmacol Exp Ther       Date:  2009-07-08       Impact factor: 4.030

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.